GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Shiller PE Ratio

Dr Reddy's Laboratories (NSE:DRREDDY) Shiller PE Ratio : 35.45 (As of Sep. 21, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dr Reddy's Laboratories Shiller PE Ratio?

As of today (2024-09-21), Dr Reddy's Laboratories's current share price is ₹6551.15. Dr Reddy's Laboratories's E10 for the quarter that ended in Jun. 2024 was ₹184.79. Dr Reddy's Laboratories's Shiller PE Ratio for today is 35.45.

The historical rank and industry rank for Dr Reddy's Laboratories's Shiller PE Ratio or its related term are showing as below:

NSE:DRREDDY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.64   Med: 32.47   Max: 55.96
Current: 35.44

During the past years, Dr Reddy's Laboratories's highest Shiller PE Ratio was 55.96. The lowest was 21.64. And the median was 32.47.

NSE:DRREDDY's Shiller PE Ratio is ranked worse than
70.3% of 468 companies
in the Drug Manufacturers industry
Industry Median: 23.995 vs NSE:DRREDDY: 35.44

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted earnings per share data for the three months ended in Jun. 2024 was ₹83.460. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹184.79 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dr Reddy's Laboratories Shiller PE Ratio Historical Data

The historical data trend for Dr Reddy's Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Shiller PE Ratio Chart

Dr Reddy's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.41 33.62 30.47 28.97 34.45

Dr Reddy's Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.68 32.56 33.05 34.45 34.65

Competitive Comparison of Dr Reddy's Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Shiller PE Ratio falls into.



Dr Reddy's Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dr Reddy's Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6551.15/184.79
=35.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Dr Reddy's Laboratories's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=83.46/155.7889*155.7889
=83.460

Current CPI (Jun. 2024) = 155.7889.

Dr Reddy's Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 33.600 96.780 54.086
201412 33.610 96.780 54.103
201503 30.350 97.163 48.663
201506 36.580 99.841 57.079
201509 42.200 101.753 64.610
201512 33.860 102.901 51.263
201603 4.373 102.518 6.645
201606 7.430 105.961 10.924
201609 17.760 105.961 26.112
201612 28.320 105.196 41.940
201703 18.830 105.196 27.886
201706 3.560 107.109 5.178
201709 17.150 109.021 24.507
201712 20.130 109.404 28.665
201803 18.180 109.786 25.798
201806 27.450 111.317 38.417
201809 30.310 115.142 41.010
201812 29.210 115.142 39.522
201903 26.160 118.202 34.479
201906 39.910 120.880 51.436
201909 65.820 123.175 83.248
201912 -34.370 126.235 -42.417
202003 46.010 124.705 57.478
202006 34.860 127.000 42.762
202009 45.830 130.118 54.872
202012 1.190 130.889 1.416
202103 33.290 131.771 39.358
202106 34.340 134.084 39.899
202109 59.650 135.847 68.406
202112 42.480 138.161 47.900
202203 5.260 138.822 5.903
202206 71.400 142.347 78.142
202209 66.890 144.661 72.035
202212 74.950 145.763 80.105
202303 57.680 146.865 61.185
202306 84.220 150.280 87.307
202309 88.780 151.492 91.298
202312 82.680 152.924 84.229
202403 78.530 153.035 79.943
202406 83.460 155.789 83.460

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dr Reddy's Laboratories  (NSE:DRREDDY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dr Reddy's Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines